We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About TwinStrand Biosciences Stock

Invest in or calculate the value of your shares in TwinStrand Biosciences or other pre-IPO companies through EquityZen's platform.

Get Started

TwinStrand Biosciences Stock (TWBI)

TwinStrand Biosciences develops and commercializes the Duplex Sequencing™ technology for DNA sequencing.

About TwinStrand Biosciences Stock

Founded

2015

Headquarters

Seattle, WA, US

Industries

Software, Artificial Intelligence, Data and Analytics

TwinStrand Biosciences improves the accuracy of DNA sequencing by >10,000 fold and allows detection of mutations that are invisible by other approaches, through its technology. Its technology, Duplex Sequencing, is based on research and has potential applications in a wide range of fields, including oncology, infectious disease, organ transplantation, reproductive and genetic health, and forensics. TwinStrand Biosciences holds an exclusive worldwide license to develop and commercialize Duplex Sequencing. It was founded in 2015 and is headquartered in Bellevue, Washington.

TwinStrand Biosciences Management

Leadership team at TwinStrand Biosciences

Chief Legal Officer

Jeff Grainger

Co-Founder & Chief Scientific Officer

Jesse Salk

Locked Features

Join now and verify your accreditation status to gain access to:

  • TwinStrand Biosciences current valuation
  • TwinStrand Biosciences stock price
  • Available deals in TwinStrand Biosciences and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in TwinStrand Biosciences stock?

Accredited investors can buy pre-IPO stock in companies like TwinStrand Biosciences through EquityZen funds. These investments are made available by existing TwinStrand Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell TwinStrand Biosciences stock?

Shareholders can sell their TwinStrand Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."